Arkolith/Insider Trading/FBRX/Form 4

Wagner Paul A.

SEE REMARKS, DirectorForte Biosciences, Inc. (FBRX) · full profile →Form 4 · filed Jan 13, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 12, 2026Grant(A)270K—$0270K
Jan 12, 2026Grant(A)180K—$0180K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001612842-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML